Sam Brusco, Associate Editor01.10.22
Johnson & Johnson Medical Devices Companies began collaborating with Microsoft to expand its secure and compliant digital surgery ecosystem. Microsoft Cloud will help J&J’s vision to advance skills, improve workflow, and enhance surgical decision making for better customer experience and improved outcomes.
J&J’s medtech comprises robotics, instrumentation, advanced imaging and visualization, data and analytics, AI, machine learning, and digital solutions. It’s important to establish connectivity between all elements with an interconnected network that meets surgeons where they are in workflow, and patients where they are in the healthcare journey.
“Collaborating with Microsoft will help take our digital approach to the next level as we create a best-in-class, unified platform across our innovative surgical technologies,” said Larry Jones, Group CIO and Global Vice President, Medical Devices, Johnson & Johnson told the press. “It brings together our collective expertise and is an exciting step towards creating a connected patient journey across the entire care continuum, before, during, and after a procedure.”
Microsoft will become J&J’s preferred cloud provider for digital surgery solutions and help the company build out its digital surgery platform and IoT device connectivity. Patient outcomes aim to be improve through AI, machine learning, and data insights. Device connectivity, insights, and intelligence will be increased using Microsoft’s Azure IoT and Edge Computing.
Azure’s capabilities and services will also be used to boost the pace of J&J’s digital surgery innovation and transformation.
“At the Johnson & Johnson Medical Devices companies, we’re shaping a future where medical intervention is smarter, less invasive, and more personalized,” said Peter Schulam, MD, PhD, Global Head, Medical Affairs, Clinical Affairs and Pre-Clinical Research, Johnson & Johnson Medical Devices Companies, and Leader, Office of Digital Innovation. “We’re excited to collaborate with Microsoft on this important work as we continue to expand our digital surgery assets and capabilities, develop innovative and advanced instrumentation, and make a meaningful clinical difference for customers and patients.”
J&J’s medtech comprises robotics, instrumentation, advanced imaging and visualization, data and analytics, AI, machine learning, and digital solutions. It’s important to establish connectivity between all elements with an interconnected network that meets surgeons where they are in workflow, and patients where they are in the healthcare journey.
“Collaborating with Microsoft will help take our digital approach to the next level as we create a best-in-class, unified platform across our innovative surgical technologies,” said Larry Jones, Group CIO and Global Vice President, Medical Devices, Johnson & Johnson told the press. “It brings together our collective expertise and is an exciting step towards creating a connected patient journey across the entire care continuum, before, during, and after a procedure.”
Microsoft will become J&J’s preferred cloud provider for digital surgery solutions and help the company build out its digital surgery platform and IoT device connectivity. Patient outcomes aim to be improve through AI, machine learning, and data insights. Device connectivity, insights, and intelligence will be increased using Microsoft’s Azure IoT and Edge Computing.
Azure’s capabilities and services will also be used to boost the pace of J&J’s digital surgery innovation and transformation.
“At the Johnson & Johnson Medical Devices companies, we’re shaping a future where medical intervention is smarter, less invasive, and more personalized,” said Peter Schulam, MD, PhD, Global Head, Medical Affairs, Clinical Affairs and Pre-Clinical Research, Johnson & Johnson Medical Devices Companies, and Leader, Office of Digital Innovation. “We’re excited to collaborate with Microsoft on this important work as we continue to expand our digital surgery assets and capabilities, develop innovative and advanced instrumentation, and make a meaningful clinical difference for customers and patients.”